These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11192337)

  • 21. A self-directed home biofeedback system for women with symptoms of stress, urge, and mixed incontinence.
    Smith DB; Boileau MA; Buan LD
    J Wound Ostomy Continence Nurs; 2000 Jul; 27(4):240-6. PubMed ID: 10896750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
    Appell RA; Sand P; Dmochowski R; Anderson R; Zinner N; Lama D; Roach M; Miklos J; Saltzstein D; Boone T; Staskin DR; Albrecht D;
    Mayo Clin Proc; 2001 Apr; 76(4):358-63. PubMed ID: 11322350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of behavioral therapy on urinary incontinence: a randomized controlled trial.
    Subak LL; Quesenberry CP; Posner SF; Cattolica E; Soghikian K
    Obstet Gynecol; 2002 Jul; 100(1):72-8. PubMed ID: 12100806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.
    Urinary Incontinence Treatment Network (UITN)
    Contemp Clin Trials; 2007 Jan; 28(1):48-58. PubMed ID: 16919506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving treatment of urinary incontinence.
    Resnick NM
    JAMA; 1998 Dec; 280(23):2034-5. PubMed ID: 9863856
    [No Abstract]   [Full Text] [Related]  

  • 28. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of coexistent stress and urge urinary incontinence.
    Karram MM; Bhatia NN
    Obstet Gynecol; 1989 Jan; 73(1):4-7. PubMed ID: 2909042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biofeedback and behavioral therapy for the management of female urinary incontinence.
    Gormley EA
    Urol Clin North Am; 2002 Aug; 29(3):551-7. PubMed ID: 12476519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial.
    Goode PS; Burgio KL; Locher JL; Roth DL; Umlauf MG; Richter HE; Varner RE; Lloyd LK
    JAMA; 2003 Jul; 290(3):345-52. PubMed ID: 12865375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating urinary incontinence in the elderly--conservative therapies that work: a systematic review.
    Teunissen TA; de Jonge A; van Weel C; Lagro-Janssen AL
    J Fam Pract; 2004 Jan; 53(1):25-30, 32. PubMed ID: 14709263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral training for stress and urge incontinence in the community.
    Burgio KL
    Gerontology; 1990; 36 Suppl 2():27-34. PubMed ID: 2227473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urinary incontinence--treatment].
    Hader C; Welz-Barth A; Keller T
    Dtsch Med Wochenschr; 2003 Apr; 128(14):750-2. PubMed ID: 12673531
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral training for urinary incontinence in elderly ambulatory patients.
    Burton JR; Pearce KL; Burgio KL; Engel BT; Whitehead WE
    J Am Geriatr Soc; 1988 Aug; 36(8):693-8. PubMed ID: 3403874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of biofeedback on psychological burden and symptoms in older women with urge urinary incontinence.
    Tadic SD; Zdaniuk B; Griffiths D; Rosenberg L; Schäfer W; Resnick NM
    J Am Geriatr Soc; 2007 Dec; 55(12):2010-5. PubMed ID: 18028340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.
    Davila GW; Daugherty CA; Sanders SW;
    J Urol; 2001 Jul; 166(1):140-5. PubMed ID: 11435842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary incontinence in women.
    Wilkinson E
    Nurs Times; 2006 Nov 28-Dec 4; 102(48):23-4. PubMed ID: 17193773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.